Acadia Pharmaceuticals Inc. · 1 week ago
Sr. Manager Business Effectiveness PMO
Princeton, NJ
Full-time
Hybrid
Mid, Senior Level
$123K/yr - $154K/yr
3+ years expAcadia Pharmaceuticals is committed to innovation in the neurological and rare disease sectors. The Sr. Manager, Business Effectiveness PMO will lead high-impact commercial programs to enhance organizational effectiveness and drive growth through strategic planning and execution of enterprise-wide initiatives.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Lead enterprise-wide commercial programs, including organizational restructures, commercialization readiness, and market expansion initiatives
Define program scope, objectives, governance, resourcing, and success metrics in partnership with Commercial leadership and executive sponsors
Develop and maintain integrated program plans, manage dependencies, track milestones, and proactively identify and mitigate risks
Ensure consistent application of PMO standards, governance, reporting, and best practices across all initiatives
Drive portfolio-level prioritization and execution to support differentiated commercial growth
Design and embed comprehensive change management strategies (communications, training, readiness, and adoption) throughout the program lifecycle
Partner with Commercial leadership and HR to manage the people impact of change and ensure successful adoption and value realization
Facilitate senior-level governance and steering committee meetings, clearly communicating program status, risks, and decision needs
Serve as a trusted advisor and central point of contact for Sales, Marketing, and Market Access leaders during periods of change
Provide oversight and direction to consulting partners supporting program execution, change management, and financial tracking
Partner with Commercial and Finance leaders to manage vendor contracts, budgets, and quarterly accrual processes
Ensure financial discipline across programs, including budget adherence, forecasting accuracy, and post-implementation value tracking
Coach and mentor program teams and functional leaders on program and change management best practices
Qualification
Required
Bachelor's degree in a related field required; equivalent experience may be considered
3–5 years of progressive experience in a commercial role, with significant exposure to cross-functional leadership
Proven experience leading complex, enterprise-wide programs supporting commercial growth and organizational change
Experience partnering with senior leaders and executive sponsors to drive alignment, decision-making, and results
Strong program and project management expertise, with deep knowledge of PMO governance, methodologies, and best practices
Demonstrated change management expertise, including leading adoption, managing resistance, and driving sustained value realization
High commercial acumen with a solid understanding of pharmaceutical commercial functions and the commercialization lifecycle
Exceptional leadership and influence skills, with the ability to drive outcomes without direct authority
Outstanding written and verbal communication skills, including the ability to present complex information clearly to executive audiences
Highly analytical and structured problem-solving approach, with strong risk management and decision-making capabilities
Preferred
Project or program management certifications preferred (e.g., PMP, Six Sigma)
Change management certification strongly preferred or demonstrated, hands-on experience applying change management principles
Prior experience in the pharmaceutical, biotech, medical device, or healthcare industry preferred
Benefits
Medical, dental, and vision insurance
Employer-paid life, disability, business travel and EAP coverage
401(k) Plan with a fully vested company match 1:1 up to 5%
Employee Stock Purchase Plan with a 2-year purchase price lock-in
15+ vacation days
13 -15 paid holidays, including office closure between December 24th and January 1st
10 days of paid sick time
Paid parental leave benefit
Tuition assistance
Company
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
501-1000 employees
H1B Sponsorship
Acadia Pharmaceuticals Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$811.73MKey Investors
National Institute of Neurological Disorders and StrokeOxford Bioscience PartnersNational Institute of Mental Health
2019-09-17Post Ipo Equity· $287.5M
2018-11-30Post Ipo Equity· $316.25M
2013-01-02Post Ipo Equity· $86.39M
Leadership Team
Catherine Adams
Chief Executive Officer
Steve Davis
President and CEO
Recent News
Company data provided by crunchbase